ADICET BIO INC (ACET) Fundamental Analysis & Valuation

NASDAQ:ACET • US0070022076

Current stock price

6.92 USD
-0.15 (-2.12%)
At close:
6.918 USD
0 (-0.03%)
After Hours:

This ACET fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. ACET Profitability Analysis

1.1 Basic Checks

  • ACET had negative earnings in the past year.
  • In the past year ACET has reported a negative cash flow from operations.
  • ACET had negative earnings in each of the past 5 years.
  • In the past 5 years ACET always reported negative operating cash flow.
ACET Yearly Net Income VS EBIT VS OCF VS FCFACET Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -50M -100M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -72.66%, ACET is doing worse than 63.83% of the companies in the same industry.
  • ACET has a Return On Equity of -88.79%. This is comparable to the rest of the industry: ACET outperforms 48.55% of its industry peers.
Industry RankSector Rank
ROA -72.66%
ROE -88.79%
ROIC N/A
ROA(3y)-47.68%
ROA(5y)-37.04%
ROE(3y)-56.8%
ROE(5y)-44.85%
ROIC(3y)N/A
ROIC(5y)N/A
ACET Yearly ROA, ROE, ROICACET Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 -50 -100 -150

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for ACET so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ACET Yearly Profit, Operating, Gross MarginsACET Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 -200 -400 -600

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. ACET Health Analysis

2.1 Basic Checks

  • The number of shares outstanding for ACET has been increased compared to 1 year ago.
  • Compared to 5 years ago, ACET has more shares outstanding
  • There is no outstanding debt for ACET. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
ACET Yearly Shares OutstandingACET Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M 5M
ACET Yearly Total Debt VS Total AssetsACET Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

  • ACET has an Altman-Z score of -5.15. This is a bad value and indicates that ACET is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of -5.15, ACET is not doing good in the industry: 63.64% of the companies in the same industry are doing better.
  • ACET has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -5.15
ROIC/WACCN/A
WACCN/A
ACET Yearly LT Debt VS Equity VS FCFACET Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

  • A Current Ratio of 7.48 indicates that ACET has no problem at all paying its short term obligations.
  • ACET's Current ratio of 7.48 is fine compared to the rest of the industry. ACET outperforms 70.79% of its industry peers.
  • A Quick Ratio of 7.48 indicates that ACET has no problem at all paying its short term obligations.
  • The Quick ratio of ACET (7.48) is better than 70.79% of its industry peers.
Industry RankSector Rank
Current Ratio 7.48
Quick Ratio 7.48
ACET Yearly Current Assets VS Current LiabilitesACET Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. ACET Growth Analysis

3.1 Past

  • ACET shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -798.25%.
EPS 1Y (TTM)-798.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1264.71%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • ACET is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 24.91% yearly.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-1142.65%
EPS Next 2Y-200.48%
EPS Next 3Y-105.46%
EPS Next 5Y24.91%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ACET Yearly Revenue VS EstimatesACET Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2028 2029 2030 2031 2032 2033 100M 200M 300M 400M 500M
ACET Yearly EPS VS EstimatesACET Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 -20 -40

More info and screens

Find the best growth stocksShow best growing peers

0

4. ACET Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for ACET. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ACET. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ACET Price Earnings VS Forward Price EarningsACET Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ACET Per share dataACET EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 -10 -15

4.3 Compensation for Growth

  • A cheap valuation may be justified as ACET's earnings are expected to decrease with -105.46% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-200.48%
EPS Next 3Y-105.46%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ACET Dividend Analysis

5.1 Amount

  • ACET does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ACET Fundamentals: All Metrics, Ratios and Statistics

ADICET BIO INC

NASDAQ:ACET (3/20/2026, 8:00:00 PM)

After market: 6.918 0 (-0.03%)

6.92

-0.15 (-2.12%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)03-04
Earnings (Next)05-04
Inst Owners59.07%
Inst Owner Change-87.79%
Ins Owners0.19%
Ins Owner Change-0.33%
Market Cap66.29M
Revenue(TTM)N/A
Net Income(TTM)-118.42M
Analysts86.15
Price Target62.73 (806.5%)
Short Float %7.57%
Short Ratio3.65
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.59%
Min EPS beat(2)-9.54%
Max EPS beat(2)8.37%
EPS beat(4)3
Avg EPS beat(4)3.58%
Min EPS beat(4)-9.54%
Max EPS beat(4)13.38%
EPS beat(8)6
Avg EPS beat(8)-1.85%
EPS beat(12)7
Avg EPS beat(12)-14.75%
EPS beat(16)9
Avg EPS beat(16)-3.2%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)709.21%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-1500%
EPS NY rev (1m)0%
EPS NY rev (3m)-1359.77%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.5
P/tB 0.5
EV/EBITDA N/A
EPS(TTM)-15.36
EYN/A
EPS(NY)-12.1
Fwd EYN/A
FCF(TTM)-10.45
FCFYN/A
OCF(TTM)-10.23
OCFYN/A
SpS0
BVpS13.92
TBVpS13.92
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -72.66%
ROE -88.79%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-47.68%
ROA(5y)-37.04%
ROE(3y)-56.8%
ROE(5y)-44.85%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 32.33%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 7.48
Quick Ratio 7.48
Altman-Z -5.15
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)246.96%
Cap/Depr(5y)333.75%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-798.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1264.71%
EPS Next Y-1142.65%
EPS Next 2Y-200.48%
EPS Next 3Y-105.46%
EPS Next 5Y24.91%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y2.01%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-32.24%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-2.32%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-17.88%
OCF growth 3YN/A
OCF growth 5YN/A

ADICET BIO INC / ACET Fundamental Analysis FAQ

What is the fundamental rating for ACET stock?

ChartMill assigns a fundamental rating of 2 / 10 to ACET.


Can you provide the valuation status for ADICET BIO INC?

ChartMill assigns a valuation rating of 0 / 10 to ADICET BIO INC (ACET). This can be considered as Overvalued.


Can you provide the profitability details for ADICET BIO INC?

ADICET BIO INC (ACET) has a profitability rating of 0 / 10.


How financially healthy is ADICET BIO INC?

The financial health rating of ADICET BIO INC (ACET) is 6 / 10.


What is the expected EPS growth for ADICET BIO INC (ACET) stock?

The Earnings per Share (EPS) of ADICET BIO INC (ACET) is expected to decline by -1142.65% in the next year.